Close menu




October 7th, 2021 | 11:15 CEST

JinkoSolar, Meta Materials, Encavis - Here comes the sun!

  • Technology
Photo credits: pixabay.com

Climate is the dominant topic of our time. Not only has the population understood this and given the Greens a record result in the last federal election, but many companies from traditional sectors such as the automotive industry or heavy industry have now accepted that only green, sustainable technology promises lasting growth. Climate-neutral energy sources are the central element. Associated with this are energy storage challenges and increasing efficiency, which is currently still far from completely replacing fossil fuels. These three stocks will benefit from the upheavals.

time to read: 4 minutes | Author: Carsten Mainitz
ISIN: JINKOSOLAR ADR/4 DL-00002 | US47759T1007 , Meta Materials Inc. | US59134N1046 , ENCAVIS AG INH. O.N. | DE0006095003

Table of contents:


    JinkoSolar - Subsidiary goes public

    In 2020, JinkoSolar announced a new world record for the efficiency of its monocrystalline n-type solar cells with 24.79%. Although this record has since been surpassed by a project of the Fraunhofer Institute with around 26%, the Chinese still remains the record holder in the field of series production. It is now to be massively expanded. At the beginning of 2021, the Company obtained permission from the Vietnamese government to build a new production plant with an annual capacity of seven gigawatts. The investment of more than USD 500 million in a production facility for wafers and ingots should enable the plant to be commissioned in the first quarter of 2022.

    JinkoSolar will thus be able to increase its annual revenue to around USD 8 billion, according to analysts, and also diversify its international supply chain. The Group is thereby responding to the strong growth in global demand for solar cells. The Chinese solar pioneer is also planning the IPO of its subsidiary Jiangxi Jinko on the STAR market of the Shanghai Stock Exchange. The necessary documents were already submitted in June and have since been accepted by the stock exchange. The next step is the registration procedure with the Chinese Securities Regulatory Commission. The Group, which holds around 73% of the subsidiary valued at USD 1.7 billion, would be diluted to a maximum shareholding of just under 55%.

    Meta Materials - Good prospects thanks to innovative materials

    The efficiency of solar cells describes how much of the incident light a solar cell can convert into electrical energy. So to maximize output, the amount of incident light must be as large as possible. Flexible systems, therefore, have a tracking control, which adjusts the orientation and angle of the sun to the current position. On the other hand, with fixed solar cells, a compromise must be found so that the maximum amount of sunlight can be captured. Meta Materials, a company based in Nova Scotia, Canada, addresses this issue with its special coatings.

    The nanomaterials developed by the NASDAQ-listed Company in more than ten years of research work, most of which have been patented, are capable of "redirecting" light, sound, heat and radio waves with the aid of virtually invisible coatings. It is thus possible to significantly increase the amount of incident light on the surfaces of solar cells without the need for tracking systems or concentrators, thus increasing the amount of electricity produced. Another possibility is to reduce the size of solar cells while maintaining the same output so that they are suitable for mobile applications, for example.

    However, the application of the materials produced by Meta Materials is not limited to the solar industry but is also suitable for dozens of other areas. For example, the transparent coating of window panes is also possible, which can then be used as antennas to improve the reception of 5G mobile communications technology. The Company has now filed 149 patent applications, and patents have already been granted for 82 of them. Investors were fascinated in the meantime, and the share price climbed to USD 22 in June. A significant price correction followed this to the current level of USD 5.30, which means that the Company is now valued at just under USD 1.5 billion.

    Another area in which Meta Materials wants to gain a foothold in the future is the topic of safety. The Canadians recently announced the complete acquisition of Nanotech Security Corp. for about CAD 91 million, a leader in developing nano-optical security features used to protect against counterfeiting of banknotes or to monitor trademark rights. For the next two years, Meta Materials has announced its intention to more than double its production capacity from the current level of around 7 million sqm to 15 million sqm per year.

    By the way: Meta Materials CEO George Palikaras will present at the International Investment Forum (IIF) on October, 14. The conference can be followed by any investor via Zoom.

    Encavis - When will the share rise again?

    One of the largest listed German solar park operators is Encavis AG, based in Hamburg. In addition to solar parks, the Company also operates numerous on-shore wind farms. The ratio of solar to wind power is currently around 3:1. The share price performance has been massively disappointing this year. Recently, however, the Company was able to announce good news. Encavis succeeded in obtaining favorable refinancing for its 21 ground-mounted wind farms in Italy (total output: around 41.7 MWp). In addition, a new special fund with a volume of EUR 500 million, aimed exclusively at banks, was launched with BayernLB, after the predecessor fund was initially doubled from EUR 200 million to EUR 400 million due to high demand, and closed with EUR 480 million in December 2020.


    Solar remains a hot topic. JinkoSolar and Encavis are attractive based on their current portfolios. In the short term, no one will break the Chinese dominance in solar module manufacturing. And German solar and wind farm operators should certainly get a tailwind with the new German government - regardless of which parties it will consist of. Meta Materials' innovative technology offers numerous application possibilities and thus addresses a vast market. After the price correction, the stock is worth a closer look.


    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may in the future hold shares or other financial instruments of the mentioned companies or will bet on rising or falling on rising or falling prices and therefore a conflict of interest may arise in the future. conflict of interest may arise in the future. The Relevant Persons reserve the shares or other financial instruments of the company at any time (hereinafter referred to as the company at any time (hereinafter referred to as a "Transaction"). "Transaction"). Transactions may under certain circumstances influence the respective price of the shares or other financial instruments of the of the Company.

    Furthermore, Apaton Finance GmbH reserves the right to enter into future relationships with the company or with third parties in relation to reports on the company. with regard to reports on the company, which are published within the scope of the Apaton Finance GmbH as well as in the social media, on partner sites or in e-mails, on partner sites or in e-mails. The above references to existing conflicts of interest apply apply to all types and forms of publication used by Apaton Finance GmbH uses for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and etc. on news.financial. These contents serve information for readers and does not constitute a call to action or recommendations, neither explicitly nor implicitly. implicitly, they are to be understood as an assurance of possible price be understood. The contents do not replace individual professional investment advice and do not constitute an offer to sell the share(s) offer to sell the share(s) or other financial instrument(s) in question, nor is it an nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but rather financial analysis, but rather journalistic or advertising texts. Readers or users who make investment decisions or carry out transactions on the basis decisions or transactions on the basis of the information provided here act completely at their own risk. There is no contractual relationship between between Apaton Finance GmbH and its readers or the users of its offers. users of its offers, as our information only refers to the company and not to the company, but not to the investment decision of the reader or user. or user.

    The acquisition of financial instruments entails high risks that can lead to the total loss of the capital invested. The information published by Apaton Finance GmbH and its authors are based on careful research on careful research, nevertheless no liability for financial losses financial losses or a content guarantee for topicality, correctness, adequacy and completeness of the contents offered here. contents offered here. Please also note our Terms of use.


    Der Autor

    Carsten Mainitz

    The native Rhineland-Palatinate has been a passionate market participant for more than 25 years. After studying business administration in Mannheim, he worked as a journalist, in equity sales and many years in equity research.

    About the author



    Related comments:

    Commented by Juliane Zielonka on September 30th, 2022 | 10:59 CEST

    Biogen, XPhyto, BioNTech: Alzheimer's disease, depression, cancer - Pharma for life

    • Biotechnology
    • Pharma
    • Investments
    • Technology

    About 350 million people worldwide are affected by depression, a disorder of the brain. Each person also has a 16 to 20% chance of becoming depressed. Reason enough for the Canadian Company XPhyto Therapeutics to research a drug that is not addictive and can defeat the mental health-related medical condition. This week, Biogen, among others, achieved a breakthrough with an active substance against Alzheimer's disease. And if you follow the Bundesliga closely, you may be aware of the cases of testicular cancer among the players. Now BioNTech senses a new opportunity...

    Read

    Commented by Fabian Lorenz on September 29th, 2022 | 13:17 CEST

    Up to 200% share price potential: Kion, BioNTech, Aspermont in analyst check

    • Technology
    • Biotechnology
    • Investments

    The profit warning was a shock for Kion shareholders. Accordingly, the share price halved to EUR 20 in September alone. Now analysts are also slashing their estimates. The price targets for the forklift manufacturer are falling accordingly. Berenberg surprises with a high price target for the BioNTech share. At the same time, the analysts emphasize their hope for a continued generous dividend. Shareholders could thus be kept in good spirits until the next blockbuster. The roadshow of Aspermont in Germany has probably also created a good mood. At least the share price has jumped. The current consolidation could be an entry opportunity. Analysts see a price potential of over 200%.

    Read

    Commented by Carsten Mainitz on September 29th, 2022 | 12:01 CEST

    Verbio, Kleos Space, KWS Saat - This news is moving share prices!

    • Space
    • Technology
    • Investments

    Increased uncertainties in geopolitics, rampant inflation with exploding commodity and energy prices, and higher interest rates are making it increasingly difficult for companies to meet the forecasts they issued at the beginning of the year. Recent examples include battery manufacturer Varta and real estate financier Hypoport, which had to withdraw their annual targets. In addition, however, a number of companies have been able to surprise on the upside despite all the challenges.

    Read